Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Newomics, Inc. logo — Enabling Precision Medicine

Newomics, Inc.

Enabling Precision Medicine

Founded 2018 United States Berkeley, United States 9 employees Series B Total: $15.72M Biotechnology, Health Care +1

General Information

Company Name Newomics, Inc.
Founded Year 2018
Location United States Berkeley, United States +1
Employees 9
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series B
Social

Get notified when Newomics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Newomics, Inc.

Newomics, Inc. is a biotech company founded in 2018 with the slogan "Enabling Precision Medicine." The company specializes in developing and selling innovative platforms for LC-MS (liquid chromatography-mass spectrometry). Their flagship product, the multinozzle M3 emitter with the MnESI ion source, has won prestigious awards for its ability to significantly enhance ionization efficiency, sensitivity, throughput, and robustness. Newomics' proprietary technology is centered around a silicon-microfluidic chip, which enables the analysis of molecules from small amounts of biospecimens like blood and urine, offering unprecedented robustness, sensitivity, specificity, and throughput. The core technology is built upon the multinozzle emitter array (MEA) technology, originally developed at the Lawrence Berkeley National Laboratory, which was the recipient of the 2012 R&D 100 award. The company recently secured a significant $7.90M Series B investment on 01 December 2020 from notable investors including the Berkeley Catalyst Fund, LDV Partners, and Photon Fund. With its focus on biotechnology and healthcare, Newomics is poised to make a substantial impact in the field of precision medicine, potentially revolutionizing the way biospecimens are analyzed and advancing medical research.

Taxonomy: Precision Medicine, Biotech, LC-MS, Multinozzle M3 Emitter, MnESI Ion Source, Silicon-microfluidic-chip, Biospecimen Analysis, Personalized Healthcare, Proprietary Technology, Innovative Platforms, Robustness, Sensitivity, Specificity, Throughput, Lawrence Berkeley National Laboratory

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 3
Investor Investor Investor
01 Dec 2020
Venture Round •••••• - 27 Oct 2020
Series A •••••• 2
Investor Investor
09 Aug 2018

Newomics, Inc. Alternatives & Competitors

Newomics, Inc. vs
ICDx
ICDx

Revolutionizing Hormone Diagnostics

Newomics, Inc. vs
Adarza BioSystems, Inc.
Adarza BioSystems, Inc. United States

Adarza’s ZIVA technology platform enables highly multiplexed label-free detection of serum analytes.

Series D
8 employees
Biotechnology, Health Care
Newomics, Inc. vs
MAT Research
MAT Research The Netherlands

The MAT Research Monocyte Activation Test: Accurate pyrogen testing, animal-free.

15 employees
AI, Automation

FAQ About Newomics, Inc.

Enabling Precision Medicine
Newomics, Inc. was founded in 2018.
Newomics, Inc. is headquartered in Berkeley, United States.
Newomics, Inc. operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Newomics, Inc. has approximately 9 employees.
Newomics, Inc. has completed 3 funding rounds, raising a total of $15.72M. The latest funding stage is Series B.
Top alternatives and competitors to Newomics, Inc. include ICDx, Adarza BioSystems, Inc., MAT Research, New Objective, Vativ Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Newomics, Inc. and ICDx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Newomics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes